Your browser doesn't support javascript.
loading
Long-Term Prospects for Telemedicine in Opioid Use Disorder (OUD) Treatment: Results from a Longitudinal Survey of OUD Clinicians.
Huskamp, Haiden A; Riedel, Lauren; Campa, Isabella; Busch, Alisa B; Rose, Sherri; Mehrotra, Ateev; Uscher-Pines, Lori.
Afiliação
  • Huskamp HA; Department of Health Care Policy, Harvard Medical School, 180A Longwood Avenue, Boston, MA, 02115, USA. Huskamp@hcp.med.harvard.edu.
  • Riedel L; Department of Health Care Policy, Harvard Medical School, 180A Longwood Avenue, Boston, MA, 02115, USA.
  • Campa I; University of California San Diego, San Diego, CA, USA.
  • Busch AB; Department of Health Care Policy, Harvard Medical School, 180A Longwood Avenue, Boston, MA, 02115, USA.
  • Rose S; McLean Hospital, Belmont, MA, USA.
  • Mehrotra A; Stanford University, Stanford, CA, USA.
  • Uscher-Pines L; Department of Health Care Policy, Harvard Medical School, 180A Longwood Avenue, Boston, MA, 02115, USA.
J Gen Intern Med ; 38(9): 2139-2146, 2023 07.
Article em En | MEDLINE | ID: mdl-36964424
ABSTRACT

BACKGROUND:

During the pandemic, there was a dramatic shift to telemedicine for opioid use disorder (OUD) treatment. Little is known about how clinician attitudes about telemedicine use for OUD treatment are evolving or their preferences for future use.

OBJECTIVE:

To understand OUD clinician views of and preferences regarding telemedicine.

DESIGN:

Longitudinal survey (wave 1, December 2020; wave 2, March 2022).

SUBJECTS:

National sample of 425 clinicians who treat OUD. MAIN

MEASURES:

Self-reported proportion of OUD visits delivered via telemedicine (actual vs. preferred), comfort in using video visits for OUD, impact of telemedicine on work-related well-being. KEY

RESULTS:

The mean reported percentage of OUD visits delivered via telemedicine (vs. in person) dropped from 56.9% in December 2020 to 41.5% in March 2022; the mean preferred post-pandemic percentage of OUD visits delivered via telemedicine was 34.8%. Responses about comfort in using video visits for different types of OUD patients remained similar over time despite clinicians having substantially more experience with telemedicine by spring 2022 (e.g., 35.8% vs. 36.0% report being comfortable using video visits for new patients). Almost three-quarters (70.9%) reported that most of their patients preferred to have the majority of their visits via telemedicine, and 76.7% agreed that the option to do video visits helped their patients remain in treatment longer. The majority (58.7%) reported that telemedicine had a positive impact on their work-related well-being, with higher rates of a positive impact among those who completed training more recently (68.5% of those with < 10 years, 62.1% with 10-19 years, and 45.8% with 20 + years, p < 0.001).

CONCLUSIONS:

While many surveyed OUD clinicians were not comfortable using telemedicine for all types of patients, most wanted telemedicine to account for a substantial fraction of OUD visits, and most believed telemedicine has had positive impacts for themselves and their patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Telemedicina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: J Gen Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Telemedicina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: J Gen Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos